title: Authors' response to Ravaioli et al.
authors.affiliation: 1 Department of Screening, Cancer Registry of Norway, Oslo, Norway.
authors.forename: Solveig
authors.initials: S
authors.lastname: Hofvind
authors.affiliation: 2 Nottingham University Hospitals NHS Trust, Nottingham, UK.
authors.forename: Rachel
authors.initials: R
authors.lastname: Bennett
authors.affiliation: 3 Centre de Recherche du, CHU de Quebec and Centre des Maladies du Sein Deschenes-Fabia, Hospital du Saint-Sacrement, Quebec, Canada.
authors.forename: Jacques
authors.initials: J
authors.lastname: Brisson
authors.affiliation: 4 Discipline Medical Radiation Sciences, the University of Sydney, Lidcombe, NSW, Australia.
authors.forename: Warwick
authors.initials: W
authors.lastname: Lee
authors.affiliation: 5 Institut National de santé Publique du Quebec, Canada.
authors.forename: Eric
authors.initials: E
authors.lastname: Pelletier
authors.affiliation: 6 CHS National Cancer Control Center, Lady Davis Carmel Medical Center, Haifa, Israel.
authors.forename: Anath
authors.initials: A
authors.lastname: Flugelman
authors.affiliation: 7 Department of Family Medicine, University of Vermont, Burlington, VT, USA.
authors.forename: Berta
authors.initials: B
authors.lastname: Geller